Chaofu Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 5
- Cancer-related gene regulation 5
- Extracellular vesicles in disease 4
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 5
- Co-authors
- Bei Shi (18 shared papers)Junbo Ge (8 shared papers)Ranzun Zhao (11 shared papers)Changyin Shen (7 shared papers)Weiwei Liu (9 shared papers)Yongchao Zhao (9 shared papers)Yan Wang (7 shared papers)Fuhai Li (5 shared papers)
- Journals
- Theranostics (3 papers)Life Sciences (3 papers)In Vitro Cellular & Developmental Biology - Animal (2 papers)Frontiers in Cardiovascular Medicine (2 papers)Molecular Therapy (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Chaofu Li
28 papers receiving 704 citations
Chaofu Li's Hit Papers
Peers
Comparison fields: 5 of 88
- Cancer Research 261
- Molecular Biology 470
- Cardiology and Cardiovascular Medicine 143
- Immunology 65
- Aging 5
Countries citing papers authored by Chaofu Li
This map shows the geographic impact of Chaofu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaofu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaofu Li more than expected).
Fields of papers citing papers by Chaofu Li
This network shows the impact of papers produced by Chaofu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaofu Li. The network helps show where Chaofu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaofu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets Hit paper breakdown → | 2023 | 124 |
| 2 | 2021 | 116 | |
| 3 | 2021 | 107 | |
| 4 | 2020 | 67 | |
| 5 | 2021 | 64 | |
| 6 | 2021 | 39 | |
| 7 | 2023 | 36 | |
| 8 | 2021 | 26 | |
| 9 | 2022 | 24 | |
| 10 | 2023 | 20 | |
| 11 | 2022 | 12 | |
| 12 | 2021 | 9 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 6 |
About Chaofu Li
Chaofu Li is a scholar working on Molecular Biology, Cancer Research, Cardiology and Cardiovascular Medicine, Immunology and Surgery, having authored 33 papers that have together received 714 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (5 papers), Cancer-related gene regulation (5 papers), Extracellular vesicles in disease (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and HVDC Systems and Fault Protection (3 papers). The work is most often cited by research in Cancer Research (261 citations), Molecular Biology (470 citations), Cardiology and Cardiovascular Medicine (143 citations), Immunology (65 citations) and Aging (5 citations). Chaofu Li has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Bei Shi, Junbo Ge, Ranzun Zhao, Changyin Shen, Weiwei Liu, Yongchao Zhao, Yan Wang, Fuhai Li, Junbo Ge and Weidong Xiong. Their work appears in journals such as Theranostics, Life Sciences, In Vitro Cellular & Developmental Biology - Animal, Frontiers in Cardiovascular Medicine and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.